Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zechen Hao"'
Autor:
Qianyu Wang, Wentao Zhong, Xiaofei Shen, Zechen Hao, Meng Wan, Xiaopeng Yang, Ran An, Hongyan Zhu, Huiyun Cai, Tao Li, Yuan Lv, Xing Dong, Gang Chen, Aijun Liu, Junfeng Du
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-10 (2024)
Abstract Tertiary lymphoid structure (TLS) contributes to the anti-tumor immune response, and predicts the prognosis of colorectal cancer patients. However, the potential impact of TLS in shaping the immune status of rectal adenocarcinoma, and the in
Externí odkaz:
https://doaj.org/article/42e19f3bc49c43a6b55fa3f58e5eb891
Autor:
Changzheng Li, Xinru You, Xi Xu, Binghuo Wu, Yuye Liu, Tong Tong, Jie Chen, Yishan Li, Chunlei Dai, Zhitao Ye, Xiaobin Tian, Yan Wei, Zechen Hao, Linjia Jiang, Jun Wu, Meng Zhao
Publikováno v:
Advanced Science, Vol 9, Iss 9, Pp n/a-n/a (2022)
Abstract Compromised immunosurveillance leads to chemotherapy resistance and disease relapse of hematological malignancies. Amino acid metabolism regulates immune responses and cancer; however, a druggable amino acid metabolite to enhance antitumor i
Externí odkaz:
https://doaj.org/article/aa43ea59e90c41b384a1ac5bb70dfaf0
Autor:
Changzheng Li, Jie Chen, Yishan Li, Binghuo Wu, Zhitao Ye, Xiaobin Tian, Yan Wei, Zechen Hao, Yuan Pan, Hongli Zhou, Keyue Yang, Zhiqiang Fu, Jingbo Xu, Yanan Lu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Hepatocellular carcinoma (HCC) has a poor prognosis due to the rapid disease progression and early metastasis. The metabolism program determines the proliferation and metastasis of HCC; however, the metabolic approach to treat HCC remains uncovered.
Externí odkaz:
https://doaj.org/article/d00e8f70360047d2a0253bd27d390997
Autor:
Xuemei Du, Xinbao Li, Bingdong Zhang, Zechen Hao, Ying Gao, Xi Jiang, Zhiran Yang, Yizhi Chen
Publikováno v:
Annals of Diagnostic Pathology. 65:152155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0522063cef2ac97163de3572807ea17
https://doi.org/10.1016/j.anndiagpath.2023.152155
https://doi.org/10.1016/j.anndiagpath.2023.152155
Autor:
Wang, Qianyu, Zhong, Wentao, Shen, Xiaofei, Hao, Zechen, Wan, Meng, Yang, Xiaopeng, An, Ran, Zhu, Hongyan, Cai, Huiyun, Li, Tao, Lv, Yuan, Dong, Xing, Chen, Gang, Liu, Aijun, Du, Junfeng
Publikováno v:
NPJ Precision Oncology; 3/2/2024, Vol. 8 Issue 1, p1-10, 10p
Autor:
Li, Changzheng1,2 (AUTHOR), You, Xinru3 (AUTHOR), Xu, Xi4 (AUTHOR), Wu, Binghuo2 (AUTHOR), Liu, Yuye1 (AUTHOR), Tong, Tong3 (AUTHOR), Chen, Jie1 (AUTHOR), Li, Yishan2 (AUTHOR), Dai, Chunlei3 (AUTHOR), Ye, Zhitao2 (AUTHOR), Tian, Xiaobin2 (AUTHOR), Wei, Yan2 (AUTHOR), Hao, Zechen2 (AUTHOR), Jiang, Linjia1 (AUTHOR) jianglj7@mail.sysu.edu.cn, Wu, Jun1,3 (AUTHOR) wujun29@mail.sysu.edu.cn, Zhao, Meng2 (AUTHOR) zhaom38@mail.sysu.edu.cn
Publikováno v:
Advanced Science. Mar2022, Vol. 9 Issue 9, p1-15. 15p.
Publikováno v:
Immunotherapy Weekly; 3/19/2024, p1145-1145, 1p